Tech entrepreneur Bryan Johnson, known for his extensive biohacking efforts to extend his lifespan, has revealed he was diagnosed with autoimmune gastritis (AIG), a chronic inflammatory condition with no known cure. Johnson, 48, shared the news on social media, stating his stomach is "eating itself" due to the disease. Despite the diagnosis, he expressed excitement about finding a solution and potentially helping millions affected by the condition.
Johnson’s Diagnosis and Response
Johnson, founder of Kernel and a former tech executive who sold Braintree to PayPal for $800 million, confirmed the diagnosis after a bidirectional endoscopy. He described the condition as "exciting" because early detection allows for proactive measures. Johnson and his team are now working to find a cure, though they remain "agnostic" about the process. He emphasized the importance of early diagnosis, stating, "The earlier you know, the better you are."
Living with Autoimmune Gastritis
AIG occurs when the immune system attacks cells that produce stomach acid, leading to nutrient absorption issues. Lori Taylor, a 60-year-old registered dietitian and AIG patient, shared her experience with the condition. She was diagnosed in 2018 but noticed symptoms as early as her 20s, including iron deficiency and stomach issues. In her 40s, symptoms worsened, causing fatigue, hair loss, and brain fog. Taylor described moments of confusion, such as forgetting simple tasks or struggling to climb stairs. Her diagnosis provided clarity, but she noted the condition is often difficult to diagnose due to its subtle onset.
Medical Context and Challenges
Autoimmune gastritis is a chronic disease characterized by the destruction of parietal cells in the stomach, according to the National Library of Medicine. The condition can lead to complications like pernicious anemia and malnutrition if left untreated. Treatment typically involves vitamin B12 supplements and dietary adjustments, but there is currently no cure. Johnson’s diagnosis has sparked discussions about the limitations of biohacking and the need for medical advancements in treating autoimmune diseases.
Public Reaction and Next Steps
Johnson thanked those who wished him well and expressed hope that his efforts could lead to a breakthrough. He framed the diagnosis as an opportunity to contribute to medical research. Meanwhile, Taylor’s story highlights the daily challenges faced by AIG patients, emphasizing the need for awareness and better diagnostic tools.